Dilution profile // every instrument, one screen, from SEC filings

Entera Bio Ltd. (ENTX)

CIK 1638097 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGH$22.3M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
LOWwarrants = 0% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
HIGH+501% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
MEDIUM~18.4 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2018-12-312026-08-03

Latest: 173.1M shares as of Aug 3, 2026 (10-Q).

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 546,028 underlying shares, as reported Dec 31, 2025 (10-K).

Reported exercise price: $5.85 (aggregate figure as tagged; individual tranches vary).

Rough fully diluted estimate: 173.7M = 173.1M O/S + 546,028 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 7, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $22.3Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3May 8, 2026$22.3M registeredfiling →
S-3May 30, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-3Feb 2, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 2 executed · 1 registered.

EXECUTEDJul 28, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
UPDATEMay 15, 2026Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEMay 15, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 8, 2026S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDApr 3, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
UPDATEJun 6, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEJun 6, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 30, 2025S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDMar 17, 2025Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDJan 10, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
UPDATEFeb 15, 2024Prospectus update — often a resale registration, not necessarily new capital424B3
REGISTEREDFeb 14, 2024S-3/A registration — capacity to sell shares, not a sale yetS-3/A

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full ENTX workspace